1 not yet recruiting, 1 recruiting, 1 withdrawn. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Nicholas Carlson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Adaptive Platform Trial for Kidney Disease APT-KIDNEY platform participation - Kidney Disease, Chronic Kidney Disease (Stages 4 and 5) | Not applicable | Not yet recruiting | Nicholas Carlson | 5000 | 2026-10-01 | 2026-06-10 |
| The Danish Pre-HCQ COVID Dialysis Study Hydroxychloroquine - COVID-19, End Stage Renal Disease | Phase 4 | Withdrawn | Nicholas Carlson | 2020-04-10 | 2026-05-19 | |
| The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis Warfarin - Atrial Fibrillation and Flutter, Stroke | Phase 4 | Recruiting | Nicholas Carlson | 718 | 2019-10-09 | 2026-05-19 |
Kidney Failure, Chronic (3) · Atrial Fibrillation (1) · COVID-19 (1) · Kidney Diseases (1) · Renal Insufficiency, Chronic (1) · Stroke (1)
Hydroxychloroquine (1) · Vitamin B 6 (1) · Warfarin (1)
Denmark (2)
Anne-Lise Kamper, MD DMSc (1) · Christian D Peters, MD PhD (1) · Christian Torp-Pedersen, Prof MD DMSc (1) · Ditte Hansen, MD PhD (1) · Ellen Linnea F Ballegaard, MD (1) · Erik Grove, MD PhD (1) · Mads Hornum, Prof MD PhD (1)
2018 (1)